Statistical Spectroscopic Tools for Biomarker Discovery and Systems Medicine

被引:52
|
作者
Robinette, Steven L. [1 ]
Lindon, John C. [1 ]
Nicholson, Jeremy K. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Surg & Canc, London SW7 2AZ, England
关键词
METABOLIC PROFILING PROCEDURES; CORRELATION NMR-SPECTROSCOPY; INFORMATION RECOVERY; STRUCTURAL INFORMATION; BIOLOGICAL TISSUES; GAS-CHROMATOGRAPHY; MASS-SPECTROMETRY; WIDE ASSOCIATION; H-1-NMR SPECTRA; DATA SETS;
D O I
10.1021/ac4007254
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
Metabolic profiling based on comparative, statistical analysis of NMR spectroscopic and mass spectrometric data from complex biological samples has contributed to increased understanding of the role of small molecules in affecting and indicating biological processes. To enable this research, the development of statistical spectroscopy has been marked by early beginnings in applying pattern recognition to nuclear magnetic resonance data and the introduction of statistical total correlation spectroscopy (STOCSY) as a tool for biomarker identification in the past decade. Extensions of statistical spectroscopy now compose a family of related tools used for compound identification, data preprocessing, and metabolic pathway analysis. In this Perspective, we review the theory and current state of research in statistical spectroscopy and discuss the growing applications of these tools to medicine and systems biology. We also provide perspectives on how recent institutional initiatives are providing new platforms for the development and application of statistical spectroscopy tools and driving the development of integrated systems medicine approaches in which clinical decision making is supported by statistical and computational analysis of metabolic, phenotypic, and physiological data.
引用
收藏
页码:5297 / 5303
页数:7
相关论文
共 50 条
  • [21] Logistic regression and other statistical tools in diagnostic biomarker studies
    Elkahwagy, Dina Mohamed Ahmed Samir
    Kiriacos, Caroline Joseph
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2024, 26 (08): : 2006 - 2019
  • [22] A statistical framework for biomarker discovery in metabolomic time course data
    Berk, Maurice
    Ebbels, Timothy
    Montana, Giovanni
    BIOINFORMATICS, 2011, 27 (14) : 1979 - 1985
  • [23] Recent development on statistical methods for personalized medicine discovery
    Zhao, Yingqi
    Zeng, Donglin
    FRONTIERS OF MEDICINE, 2013, 7 (01) : 102 - 110
  • [24] Recent development on statistical methods for personalized medicine discovery
    Yingqi Zhao
    Donglin Zeng
    Frontiers of Medicine, 2013, 7 : 102 - 110
  • [25] Statistical Considerations and Tools to Improve Histopathologic Protocols with Spectroscopic Imaging
    Mittal, Shachi
    Kim, Jonathan
    Bhargava, Rohit
    APPLIED SPECTROSCOPY, 2022, 76 (04) : 428 - 438
  • [26] Use of ex vivo systems for biomarker discovery
    LaVallie, Edward R.
    Dorner, Andrew J.
    Burczynski, Michael E.
    CURRENT OPINION IN PHARMACOLOGY, 2008, 8 (05) : 647 - 653
  • [27] Systems Approach to Neurodegenerative Disease Biomarker Discovery
    Lausted, Christopher
    Lee, Inyoul
    Zhou, Yong
    Qin, Shizhen
    Sung, Jaeyun
    Price, Nathan D.
    Hood, Leroy
    Wang, Kai
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54, 2014, 54 : 457 - 481
  • [28] Metabolomics in critical care medicine: a new approach to biomarker discovery
    Banoei, Mohammad M.
    Donnelly, Sarah J.
    Mickiewicz, Beata
    Weljie, Aalim
    Vogel, Hans J.
    Winston, Brent W.
    CLINICAL AND INVESTIGATIVE MEDICINE, 2014, 37 (06): : E363 - E376
  • [29] Biomarker discovery for drug development and translational medicine using metabonomics
    Keun, H. C.
    ONCOGENES MEET METABOLISM: FROM DEREGULATED GENES TO A BROADER UNDERSTANDING OF TUMOUR PHYSIOLOGY, 2008, 4 : 79 - 98
  • [30] Metabolomics in hepatocellular carcinoma: From biomarker discovery to precision medicine
    Wu, Xingyun
    Wang, Zihao
    Luo, Li
    Shu, Dan
    Wang, Kui
    FRONTIERS IN MEDICAL TECHNOLOGY, 2023, 4